Unichem Laboratories Ltd

Unichem Laboratories Ltd maintains a relatively strong capital structure, with a debt-to-equity ratio of 0.19, indicating a low reliance on debt financing. The company's liquidity position is assessed as medium, with a current ratio of 2.05, suggesting it has sufficient short-term assets to cover its liabilities. However, the company reported negative net cash of INR 7.9 million after subtracting total debt, which may raise concerns about its short-term liquidity.

In terms of profitability, Unichem Laboratories Ltd reported a return on equity (ROE) of 5.61% and a return on assets (ROA) of 3.85%. These figures are below the industry median for ROE and ROA, indicating that the company is underperforming relative to its peers in terms of generating returns for shareholders and asset efficiency.

The company's revenue is primarily concentrated in the Indian market, with no significant international revenue disclosed in the available data. This geographic concentration may expose the company to regulatory and economic risks specific to India, such as changes in healthcare policy or currency fluctuations.

Unichem Laboratories Ltd reported revenue of INR 21.1 billion in the latest period. While the company's growth trajectory is not explicitly outlined in the data, the absence of a significant increase in revenue or net income suggests a relatively stable but not rapidly growing business. The company's capital expenditures were INR 1.37 billion, indicating ongoing investment in infrastructure and operations.

The company's risk profile includes a medium liquidity risk, primarily due to its negative net cash position after accounting for total debt. The dilution risk is assessed as low, with no significant dilution expected in the near term. The company's free cash flow of INR 1.24 billion suggests it has the capacity to fund operations and potentially return value to shareholders.

Recent financial filings and transcripts do not indicate any major events or strategic shifts that would significantly impact the company's operations or financial performance. The company's operating cash flow was negative at INR 77 million, which may be a concern for its ability to generate internal cash to fund operations.